Translated title of the contributionThe use of janus kinase inhibitors anti-interleukin therapy in the Russian Federation with COVID-19: pharmacoepidemiological study
Original languageRussian
Pages (from-to)41-49
Number of pages9
JournalВИЧ-инфекция и иммуносупрессии
Volume15
Issue number1
DOIs
StatePublished - 30 Apr 2023

    Research areas

  • anti-interleukin drugs, janus kinase inhibitors, new coronavirus infection, pharmacoepidemiology, preventive pathogenetic therapy

ID: 106417207